Cite
HARVARD Citation
Silverberg, J. et al. (2019). Dupilumab provides important clinical benefits to patients with atopic dermatitis who do not achieve clear or almost clear skin according to the Investigator's Global Assessment: a pooled analysis of data from two phase III trials. British journal of dermatology. pp. 80-87. [Online].